Endophytic microbial platforms for sustainable production of plant-derived anticancer metabolites
Cancer continues to pose a major global health challenge, with increasing incidence and mortality worldwide. Although modern cancer therapies have advanced significantly, many clinically important anticancer drugs still originate from plant-derived secondary metabolites due to their structural diversity and potent bioactivity. Compounds such as Podophyllotoxin, Paclitaxel, Vincristine, and Camptothecin have transformed cancer treatment and serve as precursors for several clinically used therapeutics. However, their production relies largely on extraction from slow-growing and often overexploited medicinal plants such as Podophyllum hexandrum , Taxus brevifolia , Catharanthus roseus , and Camptotheca acuminata , making supply environmentally and economically unsustainable. Endophytic microorganisms have emerged as promising alternative biofactories for sustainable production of these high-value metabolites. Several fungal and bacterial endophytes, including species of Fusarium , Alternaria , Chaetomium , and Taxomyces andreanae , have been reported to produce anticancer compounds or stimulate their biosynthesis in host plants. Recent advances in synthetic biology, metabolic engineering, CRISPR-based genome editing, heterologous expression in microbial hosts, elicitor-assisted cultivation, and bioreactor-based fermentation have significantly improved metabolite yields and scalability. This review highlights recent progress in identifying endophytic producers, optimizing biosynthetic pathways, and developing industrially viable microbial platforms for sustainable production of plant-derived anticancer metabolites.
Authors
- Shiv Shanker Pandey (ORCID: https://orcid.org/0000-0001-9730-2547)
- Manju Kumari (ORCID: https://orcid.org/0000-0002-5561-0741)
- Alok Kalra (ORCID: https://orcid.org/0000-0002-3314-0179)
- Rajesh Verma (ORCID: https://orcid.org/0000-0003-0654-6656)
- Nikhil Rawat (ORCID: https://orcid.org/0000-0003-4529-9280)
- Shivam Singh Chauhan
- Riya Jaiswal
Institutions
- Institute of Himalayan Bioresource Technology (IN)
- Central Institute of Medicinal and Aromatic Plants (IN)
- Academy of Scientific and Innovative Research (IN)
Publication Details
- Journal
- Discover Life
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s11084-026-09775-z
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00